Skip to main navigation Skip to search Skip to main content

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

  • Natalie K. Heater
  • , Scott Okuno
  • , Steven Robinson
  • , Steven Attia
  • , Mahesh Seetharam
  • , Brittany L. Siontis
  • , Janet Yoon
  • , Sant Chawla
  • , Mohammed M. Milhem
  • , Varun Monga
  • , Keith Skubitz
  • , John Charlson
  • , Angela C. Hirbe
  • , Mia C. Weiss
  • , Brian Van Tine
  • , Mark Agulnik

Research output: Contribution to journalArticlepeer-review

Abstract

The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.

Original languageEnglish (US)
Article number2561
JournalJournal of Clinical Medicine
Volume12
Issue number7
DOIs
StatePublished - Apr 2023

Bibliographical note

Publisher Copyright:
© 2023 by the authors.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Midwest Sarcoma Trials Partnership
  • advanced soft tissue sarcoma
  • collaboration
  • multidisciplinary tumor board
  • sarcoma treatment
  • targeted therapy

Fingerprint

Dive into the research topics of 'The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma'. Together they form a unique fingerprint.

Cite this